Advertisement
Null Results in Brief

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

Lara E. Sucheston-Campbell, Rikki Cannioto, Alyssa I. Clay, John Lewis Etter, Kevin H. Eng, Song Liu, Sebastiano Battaglia, Qiang Hu, J. Brian Szender, Albina Minlikeeva, Janine M. Joseph, Paul Mayor, Scott I. Abrams, Brahm H. Segal, Paul K. Wallace, Kah Teong Soh, Emese Zsiros, Hoda Anton-Culver, Elisa V. Bandera, Matthias W. Beckmann, Andrew Berchuck, Line Bjorge, Amanda Bruegl, Ian G. Campbell, Shawn Patrice Campbell, Georgia Chenevix-Trench; on behalf of the Australian Ovarian Cancer Study, Daniel W. Cramer, Agnieszka Dansonka-Mieszkowska, Fanny Dao, Brenda Diergaarde, Thilo Doerk, Jennifer A. Doherty, Andreas du Bois, Diana Eccles, Svend Aage Engelholm, Peter A. Fasching, Simon A. Gayther, Aleksandra Gentry-Maharaj, Rosalind M. Glasspool, Marc T. Goodman, Jacek Gronwald, Philipp Harter, Alexander Hein, Florian Heitz, Peter Hillemmanns, Claus Høgdall, Estrid V.S. Høgdall, Tomasz Huzarski, Allan Jensen, Sharon E. Johnatty, Audrey Jung, Beth Y. Karlan, Reudiger Klapdor, Tomasz Kluz, Bożena Konopka, Susanne Krüger Kjær, Jolanta Kupryjanczyk, Diether Lambrechts, Jenny Lester, Jan Lubiński, Douglas A. Levine, Lene Lundvall, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Roberta B. Ness, Sandra Orsulic, James Paul, Celeste Leigh Pearce, Tanja Pejovic, Paul Pharoah, Susan J. Ramus, Joseph Rothstein, Mary Anne Rossing, Matthias Rübner, Joellen M. Schildkraut, Barbara Schmalfeldt, Ira Schwaab, Nadeem Siddiqui, Weiva Sieh, Piotr Sobiczewski, Honglin Song, Kathryn L. Terry, Els Van Nieuwenhuysen, Adriaan Vanderstichele, Ignace Vergote, Christine S. Walsh, Penelope M. Webb, Nicolas Wentzensen, Alice S. Whittemore, Anna H. Wu, Argyrios Ziogas, Kunle Odunsi, Jenny Chang-Claude, Ellen L. Goode and Kirsten B. Moysich
DOI: 10.1158/1055-9965.EPI-16-0631 Published March 2017

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: September 2016 to May 2021

AbstractFull-text HTMLPDF
Total4825997856

Cited By

Article Information

Volume 26, Issue 3, pp. 420-424

DOI 
https://doi.org/10.1158/1055-9965.EPI-16-0631
PubMed 
27677730
Published By 
American Association for Cancer Research
Print ISSN 
1055-9965
Online ISSN 
1538-7755
History 
  • Received August 10, 2016
  • Accepted August 26, 2016
  • Published first September 27, 2016.

Article Versions

Copyright & Usage 
©2016 American Association for Cancer Research.

Author Information

  1. Lara E. Sucheston-Campbell1,
  2. Rikki Cannioto2,
  3. Alyssa I. Clay3,
  4. John Lewis Etter2,
  5. Kevin H. Eng4,
  6. Song Liu4,
  7. Sebastiano Battaglia5,
  8. Qiang Hu4,
  9. J. Brian Szender6,
  10. Albina Minlikeeva2,
  11. Janine M. Joseph2,
  12. Paul Mayor6,
  13. Scott I. Abrams7,
  14. Brahm H. Segal7,8,
  15. Paul K. Wallace9,
  16. Kah Teong Soh9,
  17. Emese Zsiros6,
  18. Hoda Anton-Culver10,
  19. Elisa V. Bandera11,
  20. Matthias W. Beckmann12,
  21. Andrew Berchuck13,
  22. Line Bjorge14,15,
  23. Amanda Bruegl16,
  24. Ian G. Campbell17,18,
  25. Shawn Patrice Campbell16,
  26. Georgia Chenevix-Trench19; on behalf of the Australian Ovarian Cancer Study,
  27. Daniel W. Cramer20,21,
  28. Agnieszka Dansonka-Mieszkowska22,
  29. Fanny Dao23,
  30. Brenda Diergaarde24,
  31. Thilo Doerk25,
  32. Jennifer A. Doherty26,
  33. Andreas du Bois27,28,
  34. Diana Eccles29,30,
  35. Svend Aage Engelholm31,
  36. Peter A. Fasching12,
  37. Simon A. Gayther32,33,
  38. Aleksandra Gentry-Maharaj34,
  39. Rosalind M. Glasspool35,
  40. Marc T. Goodman36,37,
  41. Jacek Gronwald38,
  42. Philipp Harter27,
  43. Alexander Hein12,
  44. Florian Heitz27,28,
  45. Peter Hillemmanns25,
  46. Claus Høgdall39,
  47. Estrid V.S. Høgdall40,41,
  48. Tomasz Huzarski38,
  49. Allan Jensen40,
  50. Sharon E. Johnatty19,
  51. Audrey Jung42,43,
  52. Beth Y. Karlan44,
  53. Reudiger Klapdor25,
  54. Tomasz Kluz45,
  55. Bożena Konopka22,
  56. Susanne Krüger Kjær39,40,
  57. Jolanta Kupryjanczyk22,
  58. Diether Lambrechts46,
  59. Jenny Lester44,
  60. Jan Lubiński38,
  61. Douglas A. Levine23,
  62. Lene Lundvall47,
  63. Valerie McGuire48,
  64. Iain A. McNeish49,
  65. Usha Menon34,
  66. Francesmary Modugno24,50,51,
  67. Roberta B. Ness52,
  68. Sandra Orsulic44,
  69. James Paul35,
  70. Celeste Leigh Pearce53,54,
  71. Tanja Pejovic16,55,
  72. Paul Pharoah56,57,
  73. Susan J. Ramus58,59,
  74. Joseph Rothstein48,
  75. Mary Anne Rossing60,61,
  76. Matthias Rübner12,
  77. Joellen M. Schildkraut62,
  78. Barbara Schmalfeldt63,
  79. Ira Schwaab64,
  80. Nadeem Siddiqui65,
  81. Weiva Sieh66,67,
  82. Piotr Sobiczewski68,
  83. Honglin Song56,
  84. Kathryn L. Terry20,21,
  85. Els Van Nieuwenhuysen69,
  86. Adriaan Vanderstichele69,
  87. Ignace Vergote69,
  88. Christine S. Walsh44,
  89. Penelope M. Webb70,
  90. Nicolas Wentzensen71,
  91. Alice S. Whittemore48,
  92. Anna H. Wu54,
  93. Argyrios Ziogas72,
  94. Kunle Odunsi6,
  95. Jenny Chang-Claude42,43,
  96. Ellen L. Goode73, and
  97. Kirsten B. Moysich2,*
  1. 1College of Pharmacy, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio.
  2. 2Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
  3. 3Cancer Genetic Epidemiology, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.
  4. 4Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York.
  5. 5Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York.
  6. 6Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York.
  7. 7Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York.
  8. 8Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.
  9. 9Department of Flow & Image Cytometry, Roswell Park Cancer Institute, Buffalo, New York.
  10. 10Genetic Epidemiology Research Institute, School of Medicine, University of California Irvine, Irvine, California.
  11. 11Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
  12. 12Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  13. 13Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.
  14. 14Department of Gynecology and Obstetrics, Haukeland University Horpital, Bergen, Norway.
  15. 15Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.
  16. 16Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon.
  17. 17Cancer Genetics Laboratory, East Melbourne, Australia.
  18. 18Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
  19. 19Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Herston, Australia.
  20. 20Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts.
  21. 21Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
  22. 22Department of Pathology and Laboratory Diagnostics, the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
  23. 23Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, NYU Langone Medical Center, New York, New York.
  24. 24Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.
  25. 25Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Niedersachsen, Germany.
  26. 26Department of Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
  27. 27Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.
  28. 28Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
  29. 29Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  30. 30Wessex Clinical Genetics Service, Southampton University Hospitals Trust, Southampton, United Kingdom.
  31. 31Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  32. 32Center for Cancer Prevention and Translational Genomics, Cedars-Sinai Medical Center, Los Angeles, California.
  33. 33Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.
  34. 34Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
  35. 35The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  36. 36Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  37. 37Department of Biomedical Sciences, Community and Population Health Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  38. 38Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  39. 39Department of Gynaecology, Rigshospitalet, University of Copenhagen, Herlev, Denmark.
  40. 40Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
  41. 41Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
  42. 42Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  43. 43University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Heidelberg, Germany.
  44. 44Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  45. 45Clinic of Obstetrics and Gynecology, Institute of Midwifery and Emergency Medicine, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland.
  46. 46Department of Oncology, Laboratory for Translational Genetics, Vesalius Research Center, University of Leuven, Leuven, Belgium.
  47. 47Department of Gynecology, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  48. 48Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California.
  49. 49Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, United Kingdom.
  50. 50Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  51. 51Ovarian Cancer Center of Excellence, Womens Cancer Research Program, Magee-Womens Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
  52. 52The University of Texas School of Public Health, Houston, Texas.
  53. 53Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.
  54. 54Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  55. 55Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  56. 56Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
  57. 57Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
  58. 58School of Women's and Children's Health, University of New South Wales, New South Wales, Australia.
  59. 59The Kinghorn Cancer Centre, Garvan Institute of Medical Research, New South Wales, New South Wales, Australia.
  60. 60Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  61. 61Department of Epidemiology, University of Washington, Seattle, Washington.
  62. 62Department of Public Health Sciences, The University of Virginia, Charlottesville, Virginia.
  63. 63Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  64. 64Praxis für Humangenetik, Wiesbaden, Germany.
  65. 65Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, United Kingdom.
  66. 66Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
  67. 67Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  68. 68Department of Gynecologic Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
  69. 69Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  70. 70Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Australia.
  71. 71Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
  72. 72Department of Epidemiology, University of California Irvine, Irvine, California.
  73. 73Department of Health Science Research, Mayo Clinic, Rochester, Minnesota.
  1. ↵*Corresponding Author:
    Kirsten B. Moysich, Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. Phone: 716-845-8004; Fax: 716-845-8125; E-mail: kirsten.moysich{at}roswellpark.org
View Full Text
Back to top
Cancer Epidemiology Biomarkers & Prevention: 26 (3)
March 2017
Volume 26, Issue 3

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Email Article
Citation Tools
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival
Lara E. Sucheston-Campbell, Rikki Cannioto, Alyssa I. Clay, John Lewis Etter, Kevin H. Eng, Song Liu, Sebastiano Battaglia, Qiang Hu, J. Brian Szender, Albina Minlikeeva, Janine M. Joseph, Paul Mayor, Scott I. Abrams, Brahm H. Segal, Paul K. Wallace, Kah Teong Soh, Emese Zsiros, Hoda Anton-Culver, Elisa V. Bandera, Matthias W. Beckmann, Andrew Berchuck, Line Bjorge, Amanda Bruegl, Ian G. Campbell, Shawn Patrice Campbell, Georgia Chenevix-Trench, Daniel W. Cramer, Agnieszka Dansonka-Mieszkowska, Fanny Dao, Brenda Diergaarde, Thilo Doerk, Jennifer A. Doherty, Andreas du Bois, Diana Eccles, Svend Aage Engelholm, Peter A. Fasching, Simon A. Gayther, Aleksandra Gentry-Maharaj, Rosalind M. Glasspool, Marc T. Goodman, Jacek Gronwald, Philipp Harter, Alexander Hein, Florian Heitz, Peter Hillemmanns, Claus Høgdall, Estrid V.S. Høgdall, Tomasz Huzarski, Allan Jensen, Sharon E. Johnatty, Audrey Jung, Beth Y. Karlan, Reudiger Klapdor, Tomasz Kluz, Bożena Konopka, Susanne Krüger Kjær, Jolanta Kupryjanczyk, Diether Lambrechts, Jenny Lester, Jan Lubiński, Douglas A. Levine, Lene Lundvall, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Roberta B. Ness, Sandra Orsulic, James Paul, Celeste Leigh Pearce, Tanja Pejovic, Paul Pharoah, Susan J. Ramus, Joseph Rothstein, Mary Anne Rossing, Matthias Rübner, Joellen M. Schildkraut, Barbara Schmalfeldt, Ira Schwaab, Nadeem Siddiqui, Weiva Sieh, Piotr Sobiczewski, Honglin Song, Kathryn L. Terry, Els Van Nieuwenhuysen, Adriaan Vanderstichele, Ignace Vergote, Christine S. Walsh, Penelope M. Webb, Nicolas Wentzensen, Alice S. Whittemore, Anna H. Wu, Argyrios Ziogas, Kunle Odunsi, Jenny Chang-Claude, Ellen L. Goode and Kirsten B. Moysich on behalf of the Australian Ovarian Cancer Study
Cancer Epidemiol Biomarkers Prev March 1 2017 (26) (3) 420-424; DOI: 10.1158/1055-9965.EPI-16-0631
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement